Linical Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 12, 2024; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025
May 15, 2024 at 03:00 am EDT
Share
Linical Co., Ltd. announced dividend of JPY 15.00 per share for the fiscal year ended March 31, 2024 compared to the dividend of JPY 14.00 per share paid a year ago, payable on: June 12, 2024.
The company provided dividend guidance of JPY 16.00 per share for the fiscal year ending March 31, 2025 compared to the dividend of JPY 15.00 per share paid a year ago.
Linical Co., Ltd. is a Japan-based company mainly engaged in the contract research organization (CRO) business for drug companies. The Company operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.
Linical Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 12, 2024; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025
LINICAL CO., LTD. 
